-
1
LU-177-PSMA TREATMENT FOR METASTATIC PROSTATE CANCER – CASE EXAMPLES OF MIRACLE RESPONSES
Published 2018-03-01Subjects: Get full text
Article -
2
Characterizing PSMA heterogeneity in prostate cancer and identifying clinically actionable tumor associated antigens in PSMA negative cases
Published 2025-07-01Subjects: Get full text
Article -
3
The potential of generative AI with prostate-specific membrane antigen (PSMA) PET/CT: challenges and future directions
Published 2025-01-01Subjects: “…molecular imaging; prostate-specific membrane antigen-targeted positron emission tomography…”
Get full text
Article -
4
Detection Rates of PSMA-PET Radiopharmaceuticals in Recurrent Prostate Cancer: A Systematic Review
Published 2025-05-01Subjects: Get full text
Article -
5
A pilot study of PSMA-targeted F-18-DCFPyL PET imaging of patients with adenoid cystic carcinoma
Published 2025-05-01Subjects: Get full text
Article -
6
Clinicoradiological profile and treatment outcomes in prostate cancer at a tertiary care cancer center in India
Published 2020-01-01Subjects: Get full text
Article -
7
Fluorodeoxyglucose, sodium fluoride, and prostate-specific membrane antigen positron emission tomography studies for treatment response assessment in prostate cancer
Published 2018-07-01Subjects: “…gallium-68 prostate-specific membrane antigen…”
Get full text
Article -
8
A prospective, multi-centre trial of PSMA-PET compared to FDG-PET for staging of newly diagnosed high risk prostate cancer
Published 2025-07-01Subjects: Get full text
Article -
9
The impact of patient hydration and forced diuresis on [18F]PSMA-1007 urinary bladder uptake in PET/CT imaging
Published 2025-06-01Subjects: Get full text
Article -
10
-
11
Gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography compared with diagnostic computed tomography in relapsed prostate cancer
Published 2019-07-01Subjects: “…68gallium-prostate-specific membrane antigen positron emission tomography/computed tomography…”
Get full text
Article -
12
The impact of preliminary patient hydration on physiological [18F]PSMA-1007 uptake in the urinary bladder on PET/CT
Published 2024-06-01Subjects: Get full text
Article -
13
Can gallium-68 prostate-specific membrane antigen ligand be a potential radiotracer for renal cortical positron emission tomography imaging?
Published 2018-04-01Subjects: “…gallium-68 prostate-specific membrane antigen ligand…”
Get full text
Article -
14
Oligometastasis to testis in prostate cancer: Role of gallium-68 prostate-specific membrane antigen positron-emission tomography computed tomography
Published 2021-03-01Subjects: “…gallium-68 prostate-specific membrane antigen positron-emission tomography computed tomography…”
Get full text
Article -
15
Biomarkers to optimize PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer
Published 2025-08-01Subjects: Get full text
Article -
16
False-positive prostate cancer bone metastases on magnetic resonance imaging correctly classified on gallium-68-prostate-specific membrane antigen positron emission tomography comp...
Published 2018-10-01Subjects: “…68gallium prostate-specific membrane antigen positron emission tomography-computed tomography…”
Get full text
Article -
17
-
18
-
19
Nuclear medicine in prostate cancer: A new era for radiotracers
Published 2018-04-01Subjects: Get full text
Article -
20
The Performance and Role of PSMA PET Scans in Localised Prostate Cancer
Published 2025-02-01Subjects: Get full text
Article